解读胃癌中的耐药性:潜在的机制和未来的前景
Jiahua Liu1, Qihang Yuan1, Hui Guo1
1First Affiliated Hospital of Dalian Medical University, Dalian, China.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
|February 23, 2024
概括
胃癌化学疗法耐药性是一个日益严重的问题. 本综述探讨了抵抗机制和克服它们的策略,为晚期胃癌患者提供了希望.
科学领域:
- 在瘤学瘤学.
- 癌症研究 癌症研究
- 胃肠病学 胃肠病学
背景情况:
- 胃癌 (GC) 是全球癌症发病率和死亡率的主要原因.
- 化疗,包括FOLFOX和XELOX,是高级GC的主要治疗方法.
- 新兴的耐药性显著限制了当前化疗方案的疗效.
研究的目的:
- 探索胃癌中化疗耐药性背后的多方面的机制.
- 提出可行的策略来克服GC患者的耐药性.
主要方法:
- 审查潜在的抵抗机制,包括细胞死亡,瘤微环境,非编码RNA,表观遗传学,以及上皮-介质酶过渡.
- 分析克服抗性的策略,重点关注癌症干细胞,瘤微环境调制,天然产品和组合疗法.
主要成果:
- 在GC中,化疗耐药性是复杂的,涉及复杂的生物途径.
- 克服抗性存在多种途径,包括向癌症干细胞和调节瘤微环境.
结论:
- 了解抵抗机制对于开发有效的治疗策略至关重要.
- 针对性干预和组合疗法有望改善晚期胃癌的治疗结果.
相关概念视频
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Peptic Ulcer Disease IV: Management
92
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
92
Carrier-Mediated Transport
426
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
426


